Schedule
Posters
P2: Genomic profiles of a Northeast Thailand population in the global context – Phum Boonklang
​
P7: Scalable Endogenous Tagging by Pooled Prime Editing for Characterizing Protein Localization – Pratik Koppikar
​
P9: Causal Disentanglement for Perturbation Models of Virtual Tissues – Stathis Megas, PhD
​
P10: Flexible and efficient count-distribution and mixed-model methods for eQTL mapping with quasar – Jeffrey Pullin
​​​​​​​​​​​​​​​​​​​​​​
P1: The Genetic Drivers of Post-Cardiac Surgery Acute Kidney Injury: A Review of Risk, Recovery and Predictive Utility – Ishika Banerjee
​
P3: Using SNPs to measure the rate of brood parasitism for common bumblebee Bombus terrestris across Cambridgeshire, England – Sofia Dartnell
​
P4: Identifying high methylation entropy regions in prostate cancer tissue – Lucy Faulkner
​
P5: FOXO1-S22W Somatic Mutation Resists Insulin Inactivation and Reprograms Transcription in Chronic Liver Disease – Milena Flankova
​
P6: Systematic Dissection of the Origins of Genetic Pleiotropy across MRI-Based Neuroimaging Phenotypes through Univariate Genome-Wide Association Studies – Yuanjun Gu
​
P8: Linking Clonal Behaviours to Chromatin and Transcriptome Landscapes in HSCs at Single-Cell Resolution – Deborah Martinuzzi
​
P11: mitoSHAREseq: High-throughput mitochondrial single-cell RNA-seq and ATAC-seq – Cameron Ryall
​
P12: Leveraging Polygenic Risk Scores to Predict Type 2 Diabetes and Cardiovascular Disease After Gestational Diabetes in British Pakistani and Bangladeshi Women – Caroline Tamen
​
P13: Plasticity and genetic divergence in the adaptation to novel environments – Connie Whiting
​​
P14: Genetic architecture of intrahepatic cholestasis of pregnancy (ICP) in a British South Asian population – Xi Yang
​
P15: Genetic Basis of Early-Stage Diversification of Sexual Ornamentation in Cichlid Fish: Astatotilapia calliptera – Suhaib Yatoo
Flash talks
Speakers
Keynote: Ulrike Künzel, PhD
AstraZeneca Lead of the MRC-AstraZeneca-Milner Therapeutics Institute, University of Cambridge Functional Genomics Screening Laboratory, Associate Principal Scientist
​
Dr. Ulrike Künzel is a cell biologist. She uses her expertise in cellular phenotypic and genetic assays to direct large-scale arrayed CRISPR screens in human cell models for drug discovery. She works at the intersection of academia and industry, as the Astrazeneca lead of the Functional Genomics Screening Laboratory (FGSL), a new collaborative project between the Medical Research Council (MRC), AstraZeneca and the Milner Therapeutics Institute, University of Cambridge to uncover genetic effects on phenotypes and drug targets for chronic diseases, as part of the Human Functional Genomics Initiative.
Wes Robertson, PhD
Group Leader at the MRC Laboratory of Molecular Biology (LMB), Cambridge
​
Dr. Wes Roberston is a chemical biologist. He started his lab at the LMB in 2024 working on synthetic genomics research to advance the fields of bacterial genome design and total genome synthesis, with the aim of bringing the benefits of synthetic biology to the field of microbiome research. Previously, he worked in Prof. Jason Chin's lab at the LMB on reengineering the genetic code of the model bacteria E. coli to enable emergent applications in synthetic biology, such as viral resistance and unnatural polymer synthesis.
Gabriele Picco, PhD
Senior Staff Scientist, Wellcome Sanger Institute
​
Dr. Gabriele Picco is a cancer biologist and Senior Staff Scientist at the Wellcome Sanger Institute. His expertise lies in functional genomics, DNA repair, and biomarker-guided therapies. He contributed to the discovery of WRN helicase as a critical vulnerability in MSI tumors and has driven its translational development through integrative genomics, preclinical models, drug discovery, and mechanistic research. He leads cross-sector collaborations with academia and industry to advance novel precision oncology approaches.
Keynote: Richard Durbin, PhD, FRS
Professor of Genetics at the University of Cambridge, Associate Faculty at the Wellcome Trust Sanger Institute
​
Prof. Richard Durbin is a computational biologist. He focuses on genomic genetics, employing mathematical and computational approaches to study genetic variation, evolutionary genetics, and population genetics in humans and cichlid fishes. He also develops algorithms and software for high-throughput sequencing and genome assembly. Previously, he led major genomics projects, including the 1000 Genomes Project, UK10K, and the gorilla reference sequencing project.
Hana Aliee, PhD
Group Leader at the Cancer Research UK (CRUK), Cambridge Institute
​
Dr. Hana Aliee is a computational biologist focussing on developing AI methods to solve biological problems. She started her group this year as a Junior Group Leader at CRUK working on causal machine learning models for AI-driven scientific discovery, modelling cellular intelligence and the principles of gene regulation across individuals and contexts. Her computer science background previously led her to develop machine learning methods for single-cell genomics in Prof. Fabian Theis and Dr. Roser Vento-Tormo's labs, in Munich and Cambridge.
Tim Coorens, PhD
Group Leader, EMBL's European Bioinformatics Institute (EMBL-EBI)
Dr. Tim Coorens started his group this year at EMBL-EBI, studying how normal cells in different tissues acquire somatic mutations. His work uses mutations as inherent barcodes to study human development and the origins of cancer and develops computational tools to analyse mutations in novel single-cell and spatial data. Previously, he was an EMBO Postdoctoral Fellow working with with Prof. Gad Getz and Dr. Kristin Ardlie at the Broad Institute of MIT and Harvard.